PCN105 COST-UTILITY OF NIVOLUMAB FOR RECURRENT OR METASTATIC HEAD AND NECK CANCER (R/M SCCHN) IN FRANCE

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.302
https://www.valueinhealthjournal.com/article/S1098-3015(19)32680-4/fulltext
Title : PCN105 COST-UTILITY OF NIVOLUMAB FOR RECURRENT OR METASTATIC HEAD AND NECK CANCER (R/M SCCHN) IN FRANCE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32680-4&doi=10.1016/j.jval.2019.09.302
First page :
Section Title :
Open access? : No
Section Order : 10246
Categories :
Tags :
Regions :
ViH Article Tags :